代谢性杠杆疾病不同阶段抗高血压疗法的选择

Experimental and Clinical Gastroenterology Pub Date : 2024-03-26 DOI:10.31146/1682-8658-ecg-219-11-52-61

L. B. Lasebnik, L. N. Chikhireva, O. A. Chikhirev, E. D. Li

{"title":"代谢性杠杆疾病不同阶段抗高血压疗法的选择","authors":"L. B. Lasebnik, L. N. Chikhireva, O. A. Chikhirev, E. D. Li","doi":"10.31146/1682-8658-ecg-219-11-52-61","DOIUrl":null,"url":null,"abstract":"Metabolic dysfunction associated steatatotic liver disease (MASLD) and hypertension are two chronic progressive diseases that require a comprehensive approach. The article discusses approaches to the appointment of hypotensive and hypolipidemic therapy in patients with MASLD, depending on the stage of the disease.","PeriodicalId":12262,"journal":{"name":"Experimental and Clinical Gastroenterology","volume":"115 4","pages":""},"PeriodicalIF":0.0000,"publicationDate":"2024-03-26","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Choice of antihyprtensive therapy at varios stages of metabolically associated lever disease\",\"authors\":\"L. B. Lasebnik, L. N. Chikhireva, O. A. Chikhirev, E. D. Li\",\"doi\":\"10.31146/1682-8658-ecg-219-11-52-61\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"Metabolic dysfunction associated steatatotic liver disease (MASLD) and hypertension are two chronic progressive diseases that require a comprehensive approach. The article discusses approaches to the appointment of hypotensive and hypolipidemic therapy in patients with MASLD, depending on the stage of the disease.\",\"PeriodicalId\":12262,\"journal\":{\"name\":\"Experimental and Clinical Gastroenterology\",\"volume\":\"115 4\",\"pages\":\"\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2024-03-26\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Experimental and Clinical Gastroenterology\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.31146/1682-8658-ecg-219-11-52-61\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Experimental and Clinical Gastroenterology","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.31146/1682-8658-ecg-219-11-52-61","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}

引用次数: 0

摘要

代谢功能障碍相关性脂肪性肝病（MASLD）和高血压是两种需要综合治疗的慢性进展性疾病。文章讨论了根据疾病的不同阶段，为代谢功能障碍相关性脂肪性肝病患者指定降压和降脂治疗的方法。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

查看原文本刊更多论文

Choice of antihyprtensive therapy at varios stages of metabolically associated lever disease

Metabolic dysfunction associated steatatotic liver disease (MASLD) and hypertension are two chronic progressive diseases that require a comprehensive approach. The article discusses approaches to the appointment of hypotensive and hypolipidemic therapy in patients with MASLD, depending on the stage of the disease.

求助全文

通过发布文献求助，成功后即可免费获取论文全文。去求助

来源期刊

Experimental and Clinical Gastroenterology

CiteScore

0.80

自引率

0.00%

发文量